Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) broke out on Monday after popping out a week ago. It consolidated for four days and popped again, up 62 cents, or 9.3%, to 7.28, on 3.8 million shares traded. The target is 8 1/2-3/4. The long-term chart is outstanding, but there’s a lot of resistance up around 9.00.
Mirati Ther (NASDAQ:MRTX) broke out on Monday after consolidating for 6-7 weeks, popping 2.65, or 9.3%, to 31.10, on 617,070 shares traded. I believe it’s on its way to 40, and then 45.
Nutanix Inc (NASDAQ:NTNX) had a beautiful breakout on Monday. Double top, ran back up and blew through it, jumping 3.16, or 8%, to 42.03, on 10 million shares traded. At this point, I’m looks for 47, and then 55.
Twitter Inc (NYSE:TWTR) had a big breakaway that wedged, and on Monday it popped out of the wedge, running 1.58, or 5%, to 34.58, on 35 million shares traded, and got me back in on a swing. Targets going forward are 38 and 42.
On the long side, stocks included Adverum Biotechnologies, Inc. (ADVM), Arrowhead Pharmaceuticals, Inc. (ARWR), Atara Biotherapeutics, Inc. (ATRA), Catalyst Biosciences, Inc. (CBIO), CF Industries Holdings, Inc. (NYSE:CF), Cronos Group (CRON), 3D Systems Corporation (DDD), 8x8, Inc. (EGHT), Enphase Energy, Inc. (ENPH), FireEye, Inc. (FEYE), GTx, Inc. (GTXI), Loxo Oncology, Inc. (LOXO), Mirati Therapeutics, Inc. (MRTX), Micron Technology, Inc. (NASDAQ:MU), NUTANIX, INC. (NTNX), Stitch Fix, Inc. (SFIX), Square, Inc. (NYSE:SQ), Canopy Growth Corporation (TWMJF), Twitter, Inc. (TWTR), Upland Software, Inc. (UPLD), Vericel Corporation (VCEL), Viking Therapeutics, Inc. (VKTX), and Voyager Therapeutics, Inc. (VYGR).